143 related articles for article (PubMed ID: 23194497)
1. Letter to the editor concerning article "Design of the Trial to Assess Chelation Therapy (TACT)".
Ernst E
Am Heart J; 2012 Dec; 164(6):e23; author reply e25. PubMed ID: 23194497
[No Abstract] [Full Text] [Related]
2. Design of the Trial to Assess Chelation Therapy (TACT).
Lamas GA; Goertz C; Boineau R; Mark DB; Rozema T; Nahin RL; Drisko JA; Lee KL
Am Heart J; 2012 Jan; 163(1):7-12. PubMed ID: 22172430
[TBL] [Abstract][Full Text] [Related]
3. Chelation therapy.
Harv Heart Lett; 2002 Apr; 12(8):5-7. PubMed ID: 11959517
[No Abstract] [Full Text] [Related]
4. Chelation therapy in cardiovascular disease: an update.
Sultan S; Murarka S; Jahangir A; Mookadam F; Tajik AJ; Jahangir A
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):843-854. PubMed ID: 28597699
[TBL] [Abstract][Full Text] [Related]
5. Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.
Atwood KC; Woeckner E; Baratz RS; Sampson WI
Medscape J Med; 2008 May; 10(5):115. PubMed ID: 18596934
[TBL] [Abstract][Full Text] [Related]
6. The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).
Ujueta F; Arenas IA; Escolar E; Diaz D; Boineau R; Mark DB; Golden P; Lindblad L; Kim H; Lee KL; Lamas GA
J Diabetes Complications; 2019 Jul; 33(7):490-494. PubMed ID: 31101487
[TBL] [Abstract][Full Text] [Related]
7. Another test, another disappointment for chelation therapy.
Heart Advis; 2003 Apr; 6(4):2. PubMed ID: 12739442
[No Abstract] [Full Text] [Related]
8. [Is chelation therapy in coronary heart disease useful?].
Schnabel P; Erdmann E
Dtsch Med Wochenschr; 2002 Aug; 127(33):1715. PubMed ID: 12183807
[No Abstract] [Full Text] [Related]
9. Concerns about reliability in the Trial to Assess Chelation Therapy (TACT).
Nissen SE
JAMA; 2013 Mar; 309(12):1293-4. PubMed ID: 23532246
[No Abstract] [Full Text] [Related]
10. MY APPROACH to the use of chelation therapy.
Lamas GA
Trends Cardiovasc Med; 2016 Aug; 26(6):583-4. PubMed ID: 27199091
[No Abstract] [Full Text] [Related]
11. From the National Heart, Lung, and Blood Institute (NHLBI): EDTA chelation therapy modestly reduces cardiovascular events.
National Heart, Lung, and Blood Institute
Ethn Dis; 2013; 23(3):388. PubMed ID: 23914432
[No Abstract] [Full Text] [Related]
12. Clinical evaluation of chelation therapy: is there any wheat amidst the chaff?
Lamas GA; Ackermann A
Am Heart J; 2000 Jul; 140(1):4-5. PubMed ID: 10874253
[No Abstract] [Full Text] [Related]
13. Chelation Therapy as a Cardiovascular Therapeutic Strategy: the Rationale and the Data in Review.
Mathew RO; Schulman-Marcus J; Nichols EL; Newman JD; Bangalore S; Farkouh M; Sidhu MS
Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):619-625. PubMed ID: 29129003
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.
Bauchner H; Fontanarosa PB; Golub RM
JAMA; 2013 Mar; 309(12):1291-2. PubMed ID: 23532245
[No Abstract] [Full Text] [Related]
15. Trial to Assess Chelation Therapy (TACT) and equipoise: When evidence conflicts with beliefs.
Maron DJ; Hlatky MA
Am Heart J; 2014 Jul; 168(1):4-5. PubMed ID: 24952853
[No Abstract] [Full Text] [Related]
16. Chelation therapy for heart disease.
Baeten SM
JAAPA; 2005 Jan; 18(1):57. PubMed ID: 15675122
[No Abstract] [Full Text] [Related]
17. Understanding coronary artery disease patients' decisions regarding the use of chelation therapy for coronary artery disease: descriptive decision modeling.
King-Shier KM; Quan H; Mather C; Verhoef MJ; Knutson ML; Ghali WA
Int J Nurs Stud; 2012 Sep; 49(9):1074-83. PubMed ID: 22534492
[TBL] [Abstract][Full Text] [Related]
18. Chelation therapy for heart disease.
JAAPA; 2005 Jan; 18(1):58. PubMed ID: 15675123
[No Abstract] [Full Text] [Related]
19. Chelation therapy for intermittent claudication-a reappraisal.
Godfrey ME; Chappell LT
N Z Med J; 1996 Mar; 109(1017):83. PubMed ID: 8606830
[No Abstract] [Full Text] [Related]
20. Chelation therapy ineffective as atherosclerosis treatment.
Mayo Clin Health Lett; 2002 Jun; 20(6):4. PubMed ID: 12066805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
